Infectious Diseases News and Research

RSS

Real-world management and outcomes of U.S. patients treated with BpaL for rifampin-resistant tuberculosis

Researchers reported on the treatment of rifampin-resistant tuberculosis in the United States using the FDA approved bedaquiline, pretomanid, and linezolid (BPaL) therapy.

1 Jun 2023

What was SARS-CoV-2 antibody seroprevalence in Italian blood donors?

Researchers evaluated titers and types of severe acute respiratory syndrome coronavirus 2 antibodies in voluntary blood donors.

1 Jun 2023

Impact of healthy diet and exercise, and their interplay, on the risk of non-communicable diseases throughout a lifespan

Researchers discussed the impact of lifestyle and modifiable behaviors such as exercise and diet.

1 Jun 2023

NIH scientists identify genomic variants that cause rare inflammatory skin disorder

Researchers at the National Institutes of Health and their colleagues have identified genomic variants that cause a rare and severe inflammatory skin disorder, known as disabling pansclerotic morphea, and have found a potential treatment.

31 May 2023

Wastewater data unveils underreported Mpox cases in Texas

A recent study characterizes the analytical sensitivity of three assays used to detect MPXV in wastewater samples.

31 May 2023

Genetic change supercharged spread and severity of epizootic H5N1 avian influenza virus

St. Jude Children's Research Hospital scientists discovered how the current epizootic H5N1 avian influenza virus (bird flu) gained new genes and greater virulence as it spread west.

30 May 2023

New method may help identify the essential ingredients for making an effective HIV vaccine

Since it was identified in 1984 as the cause of Acquired Immune Deficiency Syndrome (AIDS), the human immunodeficiency virus (HIV) has infected more than 80 million people and been responsible for some 40 million deaths worldwide, according to the World Health Organization (WHO).

30 May 2023

Researchers find oldest evidence of the plague in Britain to date

Researchers at the Francis Crick Institute have identified three 4,000-year-old British cases of Yersinia pestis, the bacteria causing the plague – the oldest evidence of the plague in Britain to date, reported in a paper published today in Nature Communications.

30 May 2023

Battle against superbugs: E. coli resistance in UTIs shows slight decline

Research finds that the prevalence of antimicrobial resistance (AMR) of uropathogenic Escherichia coli (UPEC) from outpatient uncomplicated UTIs at KPSC has slightly decreased between 2016 and 2021, both for in-person and virtual settings, although the magnitude of the decrease was mostly small. Resistance to penicillins, fluoroquinolones, and TMP-SMX was common.

30 May 2023

Study identifies new genes associated with heart attack risk largely affecting younger women

Research led by the National Institute for Health and Care Research Leicester Biomedical Research Centre (BRC) and Universite Paris Cite, and supported by worldwide partners in Canada, the USA and Australia, has identified new genes that are associated with an increased risk of a type of heart attack primarily affecting young to middle-aged women.

29 May 2023

Health experts and multinationals join together to announce the formation of Movement Health Foundation

On the sidelines of the 76th World Health Assembly, Harvard University's Professor of Global Health Systems, Rifat Atun, the Copenhagen Institute for Future Studies (CIFS), Microsoft, Roche, and Siemens Healthineers came together to announce the formation of the Movement Health Foundation.

27 May 2023

Study shows how IgA acts as a "tuner" to keep the immune system in check

IgA deficiency is the most common primary immune deficiency worldwide, but its presentation has puzzled physcians and researchers.

26 May 2023

Two bacteria that co-occur with C. difficile as emerging potential threats in planetary health

A new study published in the peer-reviewed OMICS: A Journal of Integrative Biology identified genes for virulence and antimicrobial resistance in two bacteria that co-occur with C. difficile, suggesting these pathogens as emerging potential threats in planetary health.

26 May 2023

Study shows link between diet and the risk of HPV-related cancer

A study conducted by LSU Health New Orleans' Schools of Public Health and Medicine faculty reports that diet contributes to HPV infection leading to cervical cancer.

25 May 2023

T-cell-inducing mRNA COVID-19 vaccine improves effectiveness

Researchers develop a lipid nanoparticle-formulated mRNA-based antigen encoding three SARS-CoV-2 peptides derived from non-structural proteins.

25 May 2023

Novel vaccine offers hope for defeating epidemic meningitis by 2030

A trial of a new vaccine against meningococcal disease, a cause of meningitis and blood poisoning, has found that it is safe and induces a strong immune response across five strains of meningococcal bacteria: A, C, W, Y and X.

25 May 2023

Immune cells targeting core protein play an important role in early immune defense against COVID-19

LMU immunologists have studied the early immune response to acute SARS-CoV-2 infection and show how vaccines could be improved in future.

25 May 2023

Poor eating habits of university students can contribute to future health issues

A UBC Okanagan researcher is cautioning that a person's poor eating habits established during post-secondary studies can contribute to future health issues including obesity, respiratory illnesses and depression.

25 May 2023

First-in-human nanoparticle HIV vaccine induces broad and publicly targeted helper T cell responses

Researchers from Fred Hutchinson Cancer Center in Seattle, Scripps Research in La Jolla, California, IAVI and other collaborating institutions have characterized robust T-cell responses in volunteers participating in the IAVI G001 Phase 1 clinical trial to test the safety and immune response of a self-assembling nanoparticle HIV vaccine.

25 May 2023

Exercise capacity found to be lower than expected among people with long COVID

While some patients recover from the effects of SARS-CoV-2 infection, others have experienced the aftereffects of COVID-19 long after the initial infection. One of these long COVID symptoms is reduced exercise capacity.

25 May 2023

Infectious Diseases News and Research

Real-world management and outcomes of U.S. patients treated with BpaL for rifampin-resistant tuberculosis

What was SARS-CoV-2 antibody seroprevalence in Italian blood donors?

Impact of healthy diet and exercise, and their interplay, on the risk of non-communicable diseases throughout a lifespan

NIH scientists identify genomic variants that cause rare inflammatory skin disorder

Wastewater data unveils underreported Mpox cases in Texas

Genetic change supercharged spread and severity of epizootic H5N1 avian influenza virus

New method may help identify the essential ingredients for making an effective HIV vaccine

Researchers find oldest evidence of the plague in Britain to date

Battle against superbugs: E. coli resistance in UTIs shows slight decline

Study identifies new genes associated with heart attack risk largely affecting younger women

Health experts and multinationals join together to announce the formation of Movement Health Foundation

Study shows how IgA acts as a "tuner" to keep the immune system in check

Two bacteria that co-occur with C. difficile as emerging potential threats in planetary health

Study shows link between diet and the risk of HPV-related cancer

T-cell-inducing mRNA COVID-19 vaccine improves effectiveness

Novel vaccine offers hope for defeating epidemic meningitis by 2030

Immune cells targeting core protein play an important role in early immune defense against COVID-19

Poor eating habits of university students can contribute to future health issues

First-in-human nanoparticle HIV vaccine induces broad and publicly targeted helper T cell responses

Exercise capacity found to be lower than expected among people with long COVID

eBook: Advancing infectious disease vaccine development eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News